Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma
A clinical trial update evaluating whether the CD4/CD8 T-cell ratio has prognostic value in patients with Nasopharyngeal carcinoma who have …
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Prognostic Value of TIL in Nasopharyngeal Carcinoma
This entry reports a clinical trial evaluating the prognostic value of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma; the study…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: CfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection
This clinical trial compares multi-omics approaches for early nasopharyngeal carcinoma screening by integrating cfDNA methylation, Epstein-B…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial update on maintenance therapy combining toripalimab with capecitabine versus placebo for recurrent/metastatic nasopharyngeal c…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial [EARLY_Phase 1]
Exploratory EARLY_PHASE1 trial of KSD-101 for EBV-associated nasopharyngeal carcinoma; the study is not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Sintilimab Combined With Bevacizumab and TP Chemotherapy in the Treatment of High Risk Locally-advanced NPC [Phase 2]
Phase 2 trial evaluating sintilimab plus bevacizumab and TP chemotherapy for high-risk locally advanced nasopharyngeal carcinoma; study not …
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma [NA]
A clinical trial is evaluating a doxepin solution to relieve swallowing-induced pain in patients receiving radiotherapy for nasopharyngeal c…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: ChemoRT With and Without Dental Stent for Taste Protection in NPC Patients [Phase 2]
A Phase 2 study evaluating chemoradiation with vs without a dental stent for taste protection in nasopharyngeal carcinoma patients; the tria…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.). [Phase 2, Phase 3]
A clinical trial evaluating the effect of IAE0972 in combination with chemotherapy for recurrent/metastatic head and neck squamous cell carc…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT [Phase 3]
Clinical trial update describing a Phase 3 study of induction gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC [Phase 1, Phase 2]
This document updates on an ongoing Phase 1/2 trial evaluating the combination of bevacizumab and pembrolizumab for platinum-resistant local…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Treatment with Intensity Modulated Radiotherapy on the Change of Cognitive Function in Nasopharyngeal Carcinoma Patients: a Prospective Cohort Study
A prospective cohort study evaluates how intensity-modulated radiotherapy affects cognitive function in patients with nasopharyngeal carcino…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma [NA]
A clinical trial evaluating surgery alone versus surgery with dose-reduced radiotherapy for newly diagnosed stage I nasopharyngeal carcinoma…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Neoadjuvant and Adjuvant Sintilimab Combined with Chemoradiotherapy Versus Chemoradiotherapy Alone in Stage TanyN3M0 Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 trial is evaluating neoadjuvant and adjuvant sintilimab combined with chemoradiotherapy versus chemoradiotherapy alone in stage Ta…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy. [Phase 3]
A Phase 3 clinical trial (NCT06675214) is evaluating gradient fractionated radiotherapy with concurrent chemoradiotherapy plus immunotherapy…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial comparing TPC plus Cadonilimab versus TPC alone in anti-PD-1 resistant recurrent or metastatic nasopharyngeal carcinoma; the s…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal Carcinoma [NA]
A clinical trial evaluating a nurse-led individualized follow-up intervention for Nasopharyngeal Carcinoma is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Deep Learning-based sbORN Diagnostic Model
Recruiting clinical trial evaluating a deep learning-based sbORN diagnostic model for nasopharyngeal carcinoma; human herpesvirus 4 (EBV) is…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma [Phase 1]
Phase 1 clinical trial evaluating concurrent nab-paclitaxel with intensity-modulated radiation therapy in patients with stage III-IVa nasoph…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC [Phase 2]
A phase 2 clinical trial evaluating GEP combined with radiotherapy for non-locally treatable recurrent nasopharyngeal carcinoma; the study i…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Health Outcomes of Nasopharyngeal Carcinoma Patients Three Years After Treatment by the AI-assisted Home Enteral Nutrition Management [NA]
This document reports on a completed clinical trial evaluating health outcomes in nasopharyngeal carcinoma patients three years after treatm…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)
An umbrella platform clinical trial (RIBBON-Umbrella) is recruiting to study treatment individualisation based on EBV stratification in naso…
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Asian Multicenter Prospective Study of ctDNA Sequencing
Clinical trial update on an Asian multicenter prospective study evaluating circulating tumor DNA sequencing across multiple cancers, sponsor…
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: TPC VS. GP Induced Chemotherapy Combined With Nimotuzumab and Toripalimab in the Treatment of Locally Advanced Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating induction chemotherapy regimens TPC vs GP, each combined with Nimotuzumab and Toripalimab, for high-risk locally ad…
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating stereotactic radiotherapy and low-dose radiotherapy combined with a PD-1 antibody and chemotherapy in recu…